Ascend Wellness Holdings, Inc.
AAWH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.09 | 0.07 | -0.02 |
| FCF Yield | 45.94% | 17.65% | -77.88% | -11.56% |
| EV / EBITDA | 8.46 | 8.51 | 25.56 | 215.65 |
| Quality | ||||
| ROIC | 1.21% | -1.40% | -0.38% | 4.78% |
| Gross Margin | 32.80% | 29.91% | 33.15% | 40.91% |
| Cash Conversion Ratio | -0.86 | -1.56 | 0.47 | 0.34 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.43% | 15.98% | 41.35% | 202.30% |
| Free Cash Flow Growth | 8.29% | 121.40% | -26.19% | -299.90% |
| Safety | ||||
| Net Debt / EBITDA | 7.24 | 6.09 | 17.86 | 45.74 |
| Interest Coverage | 0.12 | -0.10 | -0.05 | 0.32 |
| Efficiency | ||||
| Inventory Turnover | 4.21 | 3.81 | 2.78 | 2.99 |
| Cash Conversion Cycle | 90.54 | 91.51 | 124.14 | 124.90 |